Heart valve replacement

A statistical review of 35 years' results

Gary L. Grunkemeier, Hui Hua Li, Albert Starr

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background and aims of the study: Having performed our first heart valve replacement in 1960, we began a prospective lifetime follow up service for all patients, contacting them at least annually to determine survivorship and heart valve complications. Methods: We reviewed isolated aortic (AVR) and mitral (MVR) valve replacements from 1960 to 1993, with follow up to 1998. In total, 2,942 AVR and 1,579 MVR were performed, with 21,742 and 12,142 patient-years of follow up, respectively. Analysis of the results affords an opportunity to demonstrate the usefulness and necessity of certain statistical methods, including multivariable event-free analyses and cumulative incidence functions. Results: The survival rate was 8% at 30 years for both valve positions. However, an overall survival curve is an artificial composite of patients of increasingly higher risk being served during increasingly safer years of calendar time. One result is that, for AVR, age is not a significant univariate risk factor for operative mortality, but is highly significant after accounting for date of surgery using logistic regression. Long-term mortality is higher for tissue valves than for mechanical valves; but mean age is greater (74 versus 57 years), and after accounting for age using Cox regression, mortality is similar for both valve types. Kaplan-Meier analysis estimates thromboembolism occurrences of 85% for AVR and 95% for MVR at 35 and 34 years, respectively, but the cumulative incidence estimates are only 32% and 41%, respectively. Conclusions: Prospective follow up for over 35 years has provided an opportunity to illustrate important statistical issues: Multivariate analyses are essential to avoid being misled by excluding important risk factors or including artifactual ones, and the cumulative incidence estimates the percentage of patients who will actually experience a complication.

Original languageEnglish (US)
Pages (from-to)466-471
Number of pages6
JournalJournal of Heart Valve Disease
Volume8
Issue number5
StatePublished - Sep 1999
Externally publishedYes

Fingerprint

Heart Valves
Kaplan-Meier Estimate
Mortality
Incidence
Survival Rate
Thromboembolism
Mitral Valve
Multivariate Analysis
Logistic Models
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Grunkemeier, G. L., Li, H. H., & Starr, A. (1999). Heart valve replacement: A statistical review of 35 years' results. Journal of Heart Valve Disease, 8(5), 466-471.

Heart valve replacement : A statistical review of 35 years' results. / Grunkemeier, Gary L.; Li, Hui Hua; Starr, Albert.

In: Journal of Heart Valve Disease, Vol. 8, No. 5, 09.1999, p. 466-471.

Research output: Contribution to journalArticle

Grunkemeier, GL, Li, HH & Starr, A 1999, 'Heart valve replacement: A statistical review of 35 years' results', Journal of Heart Valve Disease, vol. 8, no. 5, pp. 466-471.
Grunkemeier, Gary L. ; Li, Hui Hua ; Starr, Albert. / Heart valve replacement : A statistical review of 35 years' results. In: Journal of Heart Valve Disease. 1999 ; Vol. 8, No. 5. pp. 466-471.
@article{368b72503de84ce8b86540af00c92742,
title = "Heart valve replacement: A statistical review of 35 years' results",
abstract = "Background and aims of the study: Having performed our first heart valve replacement in 1960, we began a prospective lifetime follow up service for all patients, contacting them at least annually to determine survivorship and heart valve complications. Methods: We reviewed isolated aortic (AVR) and mitral (MVR) valve replacements from 1960 to 1993, with follow up to 1998. In total, 2,942 AVR and 1,579 MVR were performed, with 21,742 and 12,142 patient-years of follow up, respectively. Analysis of the results affords an opportunity to demonstrate the usefulness and necessity of certain statistical methods, including multivariable event-free analyses and cumulative incidence functions. Results: The survival rate was 8{\%} at 30 years for both valve positions. However, an overall survival curve is an artificial composite of patients of increasingly higher risk being served during increasingly safer years of calendar time. One result is that, for AVR, age is not a significant univariate risk factor for operative mortality, but is highly significant after accounting for date of surgery using logistic regression. Long-term mortality is higher for tissue valves than for mechanical valves; but mean age is greater (74 versus 57 years), and after accounting for age using Cox regression, mortality is similar for both valve types. Kaplan-Meier analysis estimates thromboembolism occurrences of 85{\%} for AVR and 95{\%} for MVR at 35 and 34 years, respectively, but the cumulative incidence estimates are only 32{\%} and 41{\%}, respectively. Conclusions: Prospective follow up for over 35 years has provided an opportunity to illustrate important statistical issues: Multivariate analyses are essential to avoid being misled by excluding important risk factors or including artifactual ones, and the cumulative incidence estimates the percentage of patients who will actually experience a complication.",
author = "Grunkemeier, {Gary L.} and Li, {Hui Hua} and Albert Starr",
year = "1999",
month = "9",
language = "English (US)",
volume = "8",
pages = "466--471",
journal = "The Journal of heart valve disease",
issn = "0966-8519",
publisher = "ICR Publishers Ltd",
number = "5",

}

TY - JOUR

T1 - Heart valve replacement

T2 - A statistical review of 35 years' results

AU - Grunkemeier, Gary L.

AU - Li, Hui Hua

AU - Starr, Albert

PY - 1999/9

Y1 - 1999/9

N2 - Background and aims of the study: Having performed our first heart valve replacement in 1960, we began a prospective lifetime follow up service for all patients, contacting them at least annually to determine survivorship and heart valve complications. Methods: We reviewed isolated aortic (AVR) and mitral (MVR) valve replacements from 1960 to 1993, with follow up to 1998. In total, 2,942 AVR and 1,579 MVR were performed, with 21,742 and 12,142 patient-years of follow up, respectively. Analysis of the results affords an opportunity to demonstrate the usefulness and necessity of certain statistical methods, including multivariable event-free analyses and cumulative incidence functions. Results: The survival rate was 8% at 30 years for both valve positions. However, an overall survival curve is an artificial composite of patients of increasingly higher risk being served during increasingly safer years of calendar time. One result is that, for AVR, age is not a significant univariate risk factor for operative mortality, but is highly significant after accounting for date of surgery using logistic regression. Long-term mortality is higher for tissue valves than for mechanical valves; but mean age is greater (74 versus 57 years), and after accounting for age using Cox regression, mortality is similar for both valve types. Kaplan-Meier analysis estimates thromboembolism occurrences of 85% for AVR and 95% for MVR at 35 and 34 years, respectively, but the cumulative incidence estimates are only 32% and 41%, respectively. Conclusions: Prospective follow up for over 35 years has provided an opportunity to illustrate important statistical issues: Multivariate analyses are essential to avoid being misled by excluding important risk factors or including artifactual ones, and the cumulative incidence estimates the percentage of patients who will actually experience a complication.

AB - Background and aims of the study: Having performed our first heart valve replacement in 1960, we began a prospective lifetime follow up service for all patients, contacting them at least annually to determine survivorship and heart valve complications. Methods: We reviewed isolated aortic (AVR) and mitral (MVR) valve replacements from 1960 to 1993, with follow up to 1998. In total, 2,942 AVR and 1,579 MVR were performed, with 21,742 and 12,142 patient-years of follow up, respectively. Analysis of the results affords an opportunity to demonstrate the usefulness and necessity of certain statistical methods, including multivariable event-free analyses and cumulative incidence functions. Results: The survival rate was 8% at 30 years for both valve positions. However, an overall survival curve is an artificial composite of patients of increasingly higher risk being served during increasingly safer years of calendar time. One result is that, for AVR, age is not a significant univariate risk factor for operative mortality, but is highly significant after accounting for date of surgery using logistic regression. Long-term mortality is higher for tissue valves than for mechanical valves; but mean age is greater (74 versus 57 years), and after accounting for age using Cox regression, mortality is similar for both valve types. Kaplan-Meier analysis estimates thromboembolism occurrences of 85% for AVR and 95% for MVR at 35 and 34 years, respectively, but the cumulative incidence estimates are only 32% and 41%, respectively. Conclusions: Prospective follow up for over 35 years has provided an opportunity to illustrate important statistical issues: Multivariate analyses are essential to avoid being misled by excluding important risk factors or including artifactual ones, and the cumulative incidence estimates the percentage of patients who will actually experience a complication.

UR - http://www.scopus.com/inward/record.url?scp=0032883897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032883897&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 466

EP - 471

JO - The Journal of heart valve disease

JF - The Journal of heart valve disease

SN - 0966-8519

IS - 5

ER -